Thoracic Surgical ProceduresNCT03943069
Thoracoscopic Bullectomy Versus Thoracoscopic Bullectomy With Pleurodesis in Primary Spontaneous Pneumothorax
A study testing Thoracoscopic bullectomy alone and Thoracoscopic bullectomy with pleurodesis in people with Thoracic Surgical Procedures, run by Imam Abdulrahman Bin Faisal University at 1 site in Saudi Arabia.
Trial summary
The exact pathogenesis of PSP is controversial. A few theories has been proposed contributing to the pathogenesity of the PSP as emphysematous like changes (ELCs) which lead to the formation and rupture of the lung bullae or blebs; and increased pleural porosity which is an abnormality of the visceral pleura. Read more about this study
- Who is it for?
- Ages 16 to 45 years
- Conditions the study is for
- Thoracic Surgical Procedures
- What is being tested?
- Thoracoscopic bullectomy alone and Thoracoscopic bullectomy with pleurodesis
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 232 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 1 Nov 2019to 25 Aug 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 to 45 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Primary spontaneous pneumothorax
- Male or female
- Age 16-45
Who cannot join
- Hemopneumothorax
- Previous thoracic surgical intervention
- Patient undergoing thoracotomy
Trial locations and contacts
1 site in 1 country.
Saudi Arabia1 site, 1 recruiting
- Recruiting
Imam Abdulrahman bin Faisal University
Dammam, Eastern Province, 34212
Abdullah A AlQatari, Medical student
Yaser M Aljehani, MBBS, SSC surgeon
About this study
Official title: Thoracoscopic Bullectomy Versus Thoracoscopic Bullectomy and Pleurodesis For Management of Primary Spontaneous Pneumothorax; A Prospective Multicenter Randomized Controlled Study
The exact pathogenesis of PSP is controversial. A few theories has been proposed contributing to the pathogenesity of the PSP as emphysematous like changes (ELCs) which lead to the formation and rupture of the lung bullae or blebs; and increased pleural porosity which is an abnormality of the visceral pleura. The Video-Assisted Thoracoscopic Surgery with bullectomy only is an effective preventive method of PSP recurrence. Adding mechanical pleurodesis to bullectomy is still questionable in the literature. This prospective multicenter study will identify the rate of PSP recurrence after thoracoscopic bullectomy only versus thoracoscopic bullectomy with mechanical pleurodesis.
Read the detailed description
Background The pneumothorax may be defined as presence of air in the pleural cavity which then leads to a decrease in lung expansion, and consequently lung collapse. The pneumothorax occurs due to air lodged at the pleural space either between the pleural cavity and the alveolar between the pleural cavity and the atmosphere; or the presence of organisms that produce gases (1).
The pneumothorax can be classified into spontaneous or traumatic. The spontaneous pneumothorax (SP) is either classified into primary SP that has no underlying lung disease; or secondary SP that occurs in underlying lung disease as Chronic Obstructive Pulmonary Diseases (COPDs), or in conjugation with menstrual period causing catamenial pneumothorax (1).
The exact pathogenesis of primary spontaneous pneumothorax (PSP) is controversial. The theories beyond the pathology of PSP has includes: emphysematous like changes (ELCs) which cause formation and rupture of the blebs or bullae; increased pleural porosity which is an abnormality of the visceral pleura seen under fluorescein lighting; and inflammation of the distal airways which lead to fibrotic change and compensatory emphysematous bulla (2). The development of the previous etiologies are linked to genetic predisposition, anatomical abnormalities, connective tissues abnormalities, body mass index under 18.5 kg/m2, decrease caloric intake, and apical ischemia(3).
In the literature there was a superiority in treatment of PSP with the Video-assisted thoracoscopic surgery (VATS) is in compare to thoracotomy, as it has less tissue damage, less postoperative pain, less hospitalization stay, better cosmetic outcome, and earlier return to normal daily life activities (4). The debate on the ideal preventive method of PSP recurrence using VATS spotlights on the main etiologies of the treatment of bleb and bullae by the bullectomy and the pleural abnormalities by pleurodesis(5).
VATS with bullectomy alone is an effective method of decreasing the chance of PSP recurrence, while additive of mechanical pleurodesis is questionable as different studies showed variable results(6-8). This multicenter randomized control trial study will compare the recurrence rate of PSP post thoracoscopic bullectomy alone in compare with thoracoscopic bullectomy in addition to mechanical pleurodesis.
Methodology Study setting This is a randomized control trial study which will be held at the following hospitals: King Fahad Hospital of University (KFHU), Qatif Central Hospital (QCH), King Fahad Specialist Hospital Dammam (KFSH), and John Hopkins Aramco Healthcare.
The Study will include all Saudi and non-Saudi patients, male or female, age between 16-45-year-old, diagnosed with PSP. The exclusion criteria: any patient with previous thorax surgery history, patient undergoing thoracotomy and patient with hemothorax.
Sample Size In order to calculate the sample size, the recurrence rate of the Thoracoscopic Bullectomy and Mechanical Pleurodesis (TB+MP) was conservatively estimated to be lower than 2%, whilst the recurrence rate of the Thoracoscopic Bullectomy (TB) group was estimated to be 12%. To attain a study power of 80% with an alpha error of 0.05 the sample size was estimated to be 202. Assuming a 15% loss to follow-up rate, at least 232 subjects between groups will be selected.
Randomization and Masking Computer generated randomization will be used, and to ensure random allocation and concealment, surgeons from the multiple centers that have been included will contact a central randomization service provided by a distant and blinded research fellow not involved in treatments upon arrival of patients who fulfill the inclusion criteria that have been set a priori to either the TB group or the Thoracoscopic TB+MP group.
Surgical technique The patients will be operated under general anesthesia with ventilation of one lung using double-lumen endotracheal tube.
Two or three ports thoracoscopic technique will be used to open and visualize the thoracic cavity. The procedure whether bullectomy alone or bullectomy with pleurodesis will be selected randomly preoperatively after informed consent. Wedge resection using an endoscopic stapler will target the bullae. In addition to the bullectomy the investigators will do mechanical pleurodesis according to the randomization by pleural abrasion, and consistent techniques for pleural abrasion the investigators will maintain with regard to the extent and aggressiveness of abrasion. In the mechanical pleurodesis, the mesothelial layer of the parietal pleura will be abraded from the cupola of the thoracic cavity apex to the 5th intercostal space.
Post-operatively a traditional chest drainage system will be connected to the patient's chest for monitoring the air-leak and fluid drainage. The traditional chest drainage consists of drainage chamber, water-seal chamber, and suction control.
Data Collection Medical records; chest x-ray or Computed Tomographic Scan (CT-scan) result; presenting symptoms; operative time; intraoperative blood loss; postoperative thoracic drainage amount, air-leakage duration, chest tube duration and pain scale score; length of hospital stay; and details of follow-up will be assessed by the same treating inverstigator.
All patients will be followed-up in one week, one months, three months and six months looking for pneumothorax recurrence. Nevertheless, patients will be instructed to return to the emergency department if they develop chest pain, shortness of breath, or if symptoms are suggestive of pneumothorax recurrence. All recurrence cases will be confirmed by chest X-ray or CT-scan.
Statistical analysis STATA Statistical Software version 15 will be used for data analysis. Analyses will commence with a description of the population where percentages and means along with their respective standard deviations will be reported. Multi-variate analyses will be based on the intention-to-treat principle. All tests of significance will be 2-sided. A comparison will be made between the two treatment groups based on the amount of drainage in (ml) using the hazard ratio and its respective confidence interval which will be calculated from a Cox proportional hazards model. All outcome measures will be adjusted for age, sex, smoking index, BMI, and physical activity. A p-value of less than 0.05 will be considered as statistically significant.
- Conditions
- Thoracic Surgical Procedures
- Being tested
- Thoracoscopic bullectomy alone, Thoracoscopic bullectomy with pleurodesis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Thoracoscopic bullectomy aloneProcedure or surgery
Also called VATS Bullectomy
Thoracoscopic stapling of emphysematous like changes (ELCs) to control the air leak from the lung bullae.
Thoracoscopic bullectomy with pleurodesisProcedure or surgery
Also called VATS Bullectomy with pleurodesis
Thoracoscopic stapling of emphysematous like changes (ELCs) to control the air leak from the lung bullae.in addition to mechanical pleurodesis.
| Study group | Role | What they receive |
|---|---|---|
| Patient with PSP | Experimental | Patient who will be admitted with primary spontaneous pneumothorax. Receives: Procedure: Thoracoscopic bullectomy alone; Procedure: Thoracoscopic bullectomy with pleurodesis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recurrence of pneumothorax
The evaluation of recurrence of primary spontaneous pneumothorax will be via the radiological studies (Chest x-ray) that will be performed during the follow-up visits in 1 week, 1 month, 3 months and 6 months after hospital discharge. Moreover, symptoms such as respiratory distress and ipsilateral chest pain during the follow up period will be considered as a recurrence of pneumothorax which requires further evaluation and confirmation by radiological studies. The number of recurrences during the follow up period will be compared between the two groups for any statistical difference.
Measured: 6 months
Secondary outcomes (2)
Drainage and air leak
The amount and characteristics of chest tube drainage and the degree and duration of air-leak during hospital stay will be recorded. The results will be compared between both groups and will be evaluated for any statistical difference.
Measured: 1 week
Postoperative Pain
Visual analogue scales (VAS) will assess the pain for each patient from the first day postoperative till date of hospital discharge. The scale will be used to describe the pain severity from 0 to 10. The 0 score is considered as no pain, the 5 score is considered as distressing pain, and the score at 10 is considered as the most severe pain. The result will be compared between both groups and will be evaluated for statistical difference.
Measured: 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 May 2019
- Study start1 Nov 2019
- Primary completion25 Nov 2022 (estimated)
- Study completion25 Aug 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Thoracic Surgical ProceduresStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 232 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Imam Abdulrahman Bin Faisal University
- Sponsor type
- University, hospital or other
- Collaborators
- King Fahad Specialist Hospital Dammam, Qatif Central Hospital, Johns Hopkins Aramco Healthcare
- Responsible party
- Principal investigator, Hatem Elbawab, Imam Abdulrahman Bin Faisal University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03943069
- Sponsor's protocol ID
- ThorSurg_2014-04
- Status last verified
- Nov 2020
- First submitted
- 19 Apr 2019
- Last updated
- 6 Nov 2020
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Publications
Noppen M, De Keukeleire T. Pneumothorax. Respiration. 2008;76(2):121-7. doi: 10.1159/000135932. Epub 2008 Jun 26.
PubMed 18708734Grundy S, Bentley A, Tschopp JM. Primary spontaneous pneumothorax: a diffuse disease of the pleura. Respiration. 2012;83(3):185-9. doi: 10.1159/000335993. Epub 2012 Feb 15.
PubMed 22343477Noppen M. Spontaneous pneumothorax: epidemiology, pathophysiology and cause. Eur Respir Rev. 2010 Sep;19(117):217-9. doi: 10.1183/09059180.00005310.
PubMed 20956196Huh U, Kim YD, Cho JS, I H, Lee JG, Lee JH. The Effect of Thoracoscopic Pleurodesis in Primary Spontaneous Pneumothorax: Apical Parietal Pleurectomy versus Pleural Abrasion. Korean J Thorac Cardiovasc Surg. 2012 Oct;45(5):316-9. doi: 10.5090/kjtcs.2012.45.5.316. Epub 2012 Oct 9.
PubMed 23130305Noppen M, Baumann MH. Pathogenesis and treatment of primary spontaneous pneumothorax: an overview. Respiration. 2003 Jul-Aug;70(4):431-8. doi: 10.1159/000072911.
PubMed 14512683Alayouty HD, Hasan TM, Alhadad ZA, Omar Barabba R. Mechanical versus chemical pleurodesis for management of primary spontaneous pneumothorax evaluated with thoracic echography. Interact Cardiovasc Thorac Surg. 2011 Nov;13(5):475-9. doi: 10.1510/icvts.2011.270280. Epub 2011 Aug 9.
PubMed 21828109Zhang Z, Du L, Feng H, Liang C, Liu D. Pleural abrasion should not routinely preferred in treatment of primary spontaneous pneumothorax. J Thorac Dis. 2017 Apr;9(4):1119-1125. doi: 10.21037/jtd.2017.03.124.
PubMed 28523168Horio H, Nomori H, Kobayashi R, Naruke T, Suemasu K. Impact of additional pleurodesis in video-assisted thoracoscopic bullectomy for primary spontaneous pneumothorax. Surg Endosc. 2002 Apr;16(4):630-4. doi: 10.1007/s00464-001-8232-5. Epub 2002 Jan 9.
PubMed 11972203
Study at a glance
From the registry record, last updated by the sponsor on 6 Nov 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Thoracoscopic Bullectomy Versus Thoracoscopic Bullectomy and Pleurodesis For Management of Primary Spontaneous Pneumothorax; A Prospective Multicenter Randomized Controlled Study
- ClinicalTrials.gov ID
- NCT03943069
- Acronym / sponsor ID
- ThorSurg_2014-04
- Conditions
- Thoracic Surgical Procedures
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 232 participants (estimated)
- Lead sponsor
- Imam Abdulrahman Bin Faisal UniversityUniversity, hospital or other
- Collaborators
- King Fahad Specialist Hospital Dammam, Qatif Central Hospital, Johns Hopkins Aramco Healthcare
- Study start
- 1 Nov 2019 (actual)
- Primary completion
- 25 Nov 2022 (estimated)
- Study completion
- 25 Aug 2023 (estimated)
- First posted
- 9 May 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The exact pathogenesis of PSP is controversial. A few theories has been proposed contributing to the pathogenesity of the PSP as emphysematous like changes (ELCs) which lead to the formation and rupture of the lung bullae or blebs; and increased pleural porosity which is an abnormality of the visceral pleura. The Video-Assisted Thoracoscopic Surgery with bullectomy only is an effective preventive method of PSP recurrence. Adding mechanical pleurodesis to bullectomy is still questionable in the literature. This prospective multicenter study will identify the rate of PSP recurrence after thoracoscopic bullectomy only versus thoracoscopic bullectomy with mechanical pleurodesis.
Detailed description
Background The pneumothorax may be defined as presence of air in the pleural cavity which then leads to a decrease in lung expansion, and consequently lung collapse. The pneumothorax occurs due to air lodged at the pleural space either between the pleural cavity and the alveolar between the pleural cavity and the atmosphere; or the presence of organisms that produce gases (1).
The pneumothorax can be classified into spontaneous or traumatic. The spontaneous pneumothorax (SP) is either classified into primary SP that has no underlying lung disease; or secondary SP that occurs in underlying lung disease as Chronic Obstructive Pulmonary Diseases (COPDs), or in conjugation with menstrual period causing catamenial pneumothorax (1).
The exact pathogenesis of primary spontaneous pneumothorax (PSP) is controversial. The theories beyond the pathology of PSP has includes: emphysematous like changes (ELCs) which cause formation and rupture of the blebs or bullae; increased pleural porosity which is an abnormality of the visceral pleura seen under fluorescein lighting; and inflammation of the distal airways which lead to fibrotic change and compensatory emphysematous bulla (2). The development of the previous etiologies are linked to genetic predisposition, anatomical abnormalities, connective tissues abnormalities, body mass index under 18.5 kg/m2, decrease caloric intake, and apical ischemia(3).
In the literature there was a superiority in treatment of PSP with the Video-assisted thoracoscopic surgery (VATS) is in compare to thoracotomy, as it has less tissue damage, less postoperative pain, less hospitalization stay, better cosmetic outcome, and earlier return to normal daily life activities (4). The debate on the ideal preventive method of PSP recurrence using VATS spotlights on the main etiologies of the treatment of bleb and bullae by the bullectomy and the pleural abnormalities by pleurodesis(5).
VATS with bullectomy alone is an effective method of decreasing the chance of PSP recurrence, while additive of mechanical pleurodesis is questionable as different studies showed variable results(6-8). This multicenter randomized control trial study will compare the recurrence rate of PSP post thoracoscopic bullectomy alone in compare with thoracoscopic bullectomy in addition to mechanical pleurodesis.
Methodology Study setting This is a randomized control trial study which will be held at the following hospitals: King Fahad Hospital of University (KFHU), Qatif Central Hospital (QCH), King Fahad Specialist Hospital Dammam (KFSH), and John Hopkins Aramco Healthcare.
The Study will include all Saudi and non-Saudi patients, male or female, age between 16-45-year-old, diagnosed with PSP. The exclusion criteria: any patient with previous thorax surgery history, patient undergoing thoracotomy and patient with hemothorax.
Sample Size In order to calculate the sample size, the recurrence rate of the Thoracoscopic Bullectomy and Mechanical Pleurodesis (TB+MP) was conservatively estimated to be lower than 2%, whilst the recurrence rate of the Thoracoscopic Bullectomy (TB) group was estimated to be 12%. To attain a study power of 80% with an alpha error of 0.05 the sample size was estimated to be 202. Assuming a 15% loss to follow-up rate, at least 232 subjects between groups will be selected.
Randomization and Masking Computer generated randomization will be used, and to ensure random allocation and concealment, surgeons from the multiple centers that have been included will contact a central randomization service provided by a distant and blinded research fellow not involved in treatments upon arrival of patients who fulfill the inclusion criteria that have been set a priori to either the TB group or the Thoracoscopic TB+MP group.
Surgical technique The patients will be operated under general anesthesia with ventilation of one lung using double-lumen endotracheal tube.
Two or three ports thoracoscopic technique will be used to open and visualize the thoracic cavity. The procedure whether bullectomy alone or bullectomy with pleurodesis will be selected randomly preoperatively after informed consent. Wedge resection using an endoscopic stapler will target the bullae. In addition to the bullectomy the investigators will do mechanical pleurodesis according to the randomization by pleural abrasion, and consistent techniques for pleural abrasion the investigators will maintain with regard to the extent and aggressiveness of abrasion. In the mechanical pleurodesis, the mesothelial layer of the parietal pleura will be abraded from the cupola of the thoracic cavity apex to the 5th intercostal space.
Post-operatively a traditional chest drainage system will be connected to the patient's chest for monitoring the air-leak and fluid drainage. The traditional chest drainage consists of drainage chamber, water-seal chamber, and suction control.
Data Collection Medical records; chest x-ray or Computed Tomographic Scan (CT-scan) result; presenting symptoms; operative time; intraoperative blood loss; postoperative thoracic drainage amount, air-leakage duration, chest tube duration and pain scale score; length of hospital stay; and details of follow-up will be assessed by the same treating inverstigator.
All patients will be followed-up in one week, one months, three months and six months looking for pneumothorax recurrence. Nevertheless, patients will be instructed to return to the emergency department if they develop chest pain, shortness of breath, or if symptoms are suggestive of pneumothorax recurrence. All recurrence cases will be confirmed by chest X-ray or CT-scan.
Statistical analysis STATA Statistical Software version 15 will be used for data analysis. Analyses will commence with a description of the population where percentages and means along with their respective standard deviations will be reported. Multi-variate analyses will be based on the intention-to-treat principle. All tests of significance will be 2-sided. A comparison will be made between the two treatment groups based on the amount of drainage in (ml) using the hazard ratio and its respective confidence interval which will be calculated from a Cox proportional hazards model. All outcome measures will be adjusted for age, sex, smoking index, BMI, and physical activity. A p-value of less than 0.05 will be considered as statistically significant.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patient with PSP | Experimental | Procedure: Thoracoscopic bullectomy alone, Procedure: Thoracoscopic bullectomy with pleurodesisPatient who will be admitted with primary spontaneous pneumothorax. |
Who may qualify
- Ages
- 16 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Primary spontaneous pneumothorax
- Male or female
- Age 16-45
Key exclusion criteria (3 listed)
- Hemopneumothorax
- Previous thoracic surgical intervention
- Patient undergoing thoracotomy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Thoracoscopic bullectomy aloneAlso: VATS BullectomyThoracoscopic stapling of emphysematous like changes (ELCs) to control the air leak from the lung bullae. | Procedure or surgery | Patient with PSP |
| Thoracoscopic bullectomy with pleurodesisAlso: VATS Bullectomy with pleurodesisThoracoscopic stapling of emphysematous like changes (ELCs) to control the air leak from the lung bullae.in addition to mechanical pleurodesis. | Procedure or surgery | Patient with PSP |
Primary outcome
Recurrence of pneumothorax
Time frame: 6 months
The evaluation of recurrence of primary spontaneous pneumothorax will be via the radiological studies (Chest x-ray) that will be performed during the follow-up visits in 1 week, 1 month, 3 months and 6 months after hospital discharge. Moreover, symptoms such as respiratory distress and ipsilateral chest pain during the follow up period will be considered as a recurrence of pneumothorax which requires further evaluation and confirmation by radiological studies. The number of recurrences during the follow up period will be compared between the two groups for any statistical difference.
2 secondary outcomes
Drainage and air leak
Time frame: 1 week
Postoperative Pain
Time frame: 1 week
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Nov 2020.
- Background: PubMed 18708734Noppen M, De Keukeleire T. Pneumothorax. Respiration. 2008;76(2):121-7. doi: 10.1159/000135932. Epub 2008 Jun 26.
- Background: PubMed 22343477Grundy S, Bentley A, Tschopp JM. Primary spontaneous pneumothorax: a diffuse disease of the pleura. Respiration. 2012;83(3):185-9. doi: 10.1159/000335993. Epub 2012 Feb 15.
- Background: PubMed 20956196Noppen M. Spontaneous pneumothorax: epidemiology, pathophysiology and cause. Eur Respir Rev. 2010 Sep;19(117):217-9. doi: 10.1183/09059180.00005310.
- Background: PubMed 23130305Huh U, Kim YD, Cho JS, I H, Lee JG, Lee JH. The Effect of Thoracoscopic Pleurodesis in Primary Spontaneous Pneumothorax: Apical Parietal Pleurectomy versus Pleural Abrasion. Korean J Thorac Cardiovasc Surg. 2012 Oct;45(5):316-9. doi: 10.5090/kjtcs.2012.45.5.316. Epub 2012 Oct 9.
- Background: PubMed 14512683Noppen M, Baumann MH. Pathogenesis and treatment of primary spontaneous pneumothorax: an overview. Respiration. 2003 Jul-Aug;70(4):431-8. doi: 10.1159/000072911.
- Background: PubMed 21828109Alayouty HD, Hasan TM, Alhadad ZA, Omar Barabba R. Mechanical versus chemical pleurodesis for management of primary spontaneous pneumothorax evaluated with thoracic echography. Interact Cardiovasc Thorac Surg. 2011 Nov;13(5):475-9. doi: 10.1510/icvts.2011.270280. Epub 2011 Aug 9.
- Results publication: PubMed 28523168Zhang Z, Du L, Feng H, Liang C, Liu D. Pleural abrasion should not routinely preferred in treatment of primary spontaneous pneumothorax. J Thorac Dis. 2017 Apr;9(4):1119-1125. doi: 10.21037/jtd.2017.03.124.
- Results publication: PubMed 11972203Horio H, Nomori H, Kobayashi R, Naruke T, Suemasu K. Impact of additional pleurodesis in video-assisted thoracoscopic bullectomy for primary spontaneous pneumothorax. Surg Endosc. 2002 Apr;16(4):630-4. doi: 10.1007/s00464-001-8232-5. Epub 2002 Jan 9.
- Individual participant dataSharing planned: Yes
Related trials for Thoracic Surgical Procedures
Recruiting
Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)
Thoracic
Not yet recruitingPhase 4
Methadone Versus Standard of Care for Pain Control in Minimally Invasive Lung Resection Surgery
Pain Management
Recruiting
Effect of Box Breathing Before Chest Tube Removal After Open-Heart Surgery
Open-Heart Surgery
RecruitingObservational study
Hemodynamic Evaluation and Assessment of DIRECT myocaRdial and Sublingual Capillary Perfusion in Thoracic Surgery Patients on Cardiopulmonary Bypass
Microcirculatory Perfusion
RecruitingObservational study
Pain Control and Recovery After Thoracic Surgery Using SPSIP Block
Postoperative Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Thoracoscopic bullectomy alone and Thoracoscopic bullectomy with pleurodesis in people with Thoracic Surgical Procedures, run by Imam Abdulrahman Bin Faisal University at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hatem Y El-Bawab, Doctorate (+966537395536, HYBawab@iau.edu.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recurrence of pneumothorax (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03943069, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2020.